Search

everythinglearnresearchcommunity

for

Search:↓

Healthcare claims databases can help monitor drug safety, but may report adverse events differently than direct surveillance.

Ripretinib is effective and safe for treating advanced GIST in Chinese patients, particularly for non-gastric GISTs.

JAK inhibitors help treat some diseases but may increase risks of blood clots and cancer in certain patients.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

New treatments may restore cancer-blocking proteins, slow prostate cancer, identify drug targets, and potentially regrow hair.

Stopping gefitinib improved scalp condition in a woman with lung cancer.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

Nobiletin-loaded vesicles effectively treat skin cancer by restoring normal miRNA and antioxidant levels.

Tislelizumab can cause cutaneous lupus erythematosus.

ALRN-6924 may prevent hair loss caused by chemotherapy.

Targeted cancer drugs can cause skin reactions, so dermatologists must manage these effects.

Two new compounds were found to effectively reduce hair growth in mice.

A woman with advanced eye cancer went into complete remission using a combination of immunotherapy and topical treatments.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.

Upadacitinib helped regrow hair and maintain ulcerative colitis remission.

Apremilast showed mixed results for treating severe alopecia areata.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Talquetamab may cause hair loss and skin issues.

Selaginella doederleinii extract shows potential for cervical cancer treatment but needs more research.

China approved Sinovac's flu vaccine, Japan approved RiUP for female hair loss, and Nippon Kayaku's three cancer drugs.

Serenoa repens extract shows promise as a natural treatment for prostate cancer.

Nanostructured lipid carriers effectively deliver tofacitinib to hair follicles, reversing hair loss in alopecia areata.

Tyrosine Kinase Inhibitors are effective against cancer but can cause skin, digestive, and blood side effects, including hair loss.

Tofacitinib improved hair loss and skin symptoms in a patient after secukinumab caused hair loss.

Tofacitinib may help treat hair loss in children with alopecia areata.

Clotrimazole, an antifungal cream, may safely reduce skin pigmentation by breaking down the enzyme needed for making melanin.

Baricitinib improved hair loss and arthritis in a lupus patient.

The new treatment was safe and may effectively treat male pattern hair loss.